Sonoma Pharmaceuticals (SNOA) Return on Sales (2010 - 2025)

Sonoma Pharmaceuticals' Return on Sales history runs 16 years deep, the most recent figure standing at 0.0% for Q4 2025.

• In Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q4 2025 at Sonoma Pharmaceuticals, down from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q1 2021 to a low of 0.01% in Q4 2022.
• Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2023.
• Biggest YoY gain for Return on Sales was 0 bps in 2021; the steepest drop was 0 bps in 2021.
• A 5-year view of Return on Sales shows it stood at 0.0% in 2021, then tumbled by 39750 bps to 0.01% in 2022, then surged by 58 bps to 0.0% in 2023, then increased by 6 bps to 0.0% in 2024, then rose by 28 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.